Followers | 65 |
Posts | 4647 |
Boards Moderated | 0 |
Alias Born | 02/12/2013 |
Tuesday, December 08, 2020 2:30:50 PM
CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.
Recent PEN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 11:29:53 PM
- Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe • PR Newswire (US) • 09/16/2024 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 11:48:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/04/2024 08:13:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 11:02:44 PM
- Penumbra, Inc. to Present at the Baird Global Healthcare Conference • PR Newswire (US) • 08/27/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 11:46:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2024 08:49:10 PM
- Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference • PR Newswire (US) • 08/21/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 11:41:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:05:30 AM
- Penumbra, Inc. Announces $200 Million Share Repurchase Authorization • PR Newswire (US) • 08/13/2024 11:00:00 AM
- Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference • PR Newswire (US) • 08/02/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/30/2024 08:45:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:15:04 PM
- Penumbra, Inc. Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 07/30/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 11:31:39 PM
- Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 • PR Newswire (US) • 07/02/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:33:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 11:31:19 PM
- Penumbra, Inc. to Present at the Truist Securities MedTech Conference • PR Newswire (US) • 06/04/2024 08:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 09:12:59 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 08:39:38 PM
- Penumbra, Inc. to Present at the William Blair Growth Stock Conference • PR Newswire (US) • 05/23/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 11:38:56 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM